These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Assessment of inverse agonism for the angiotensin II type 1 receptor. Akazawa H; Yasuda N; Miura S; Komuro I Methods Enzymol; 2010; 485():25-35. PubMed ID: 21050909 [TBL] [Abstract][Full Text] [Related]
51. A pharmacological primer of biased agonism. Andresen BT Endocr Metab Immune Disord Drug Targets; 2011 Jun; 11(2):92-8. PubMed ID: 21476970 [TBL] [Abstract][Full Text] [Related]
52. Conceptual and experimental issues in biased agonism. Onaran HO; Costa T Cell Signal; 2021 Jun; 82():109955. PubMed ID: 33607257 [TBL] [Abstract][Full Text] [Related]
53. How inverse can a neutral antagonist be? Strategic questions after the rimonabant issue. Giraldo J Drug Discov Today; 2010 Jun; 15(11-12):411-5. PubMed ID: 20447467 [TBL] [Abstract][Full Text] [Related]
54. A robust and high-capacity [(35)S]GTPgammaS binding assay for determining antagonist and inverse agonist pharmacological parameters of histamine H(3) receptor ligands. Miller TR; Baranowski JL; Estvander BR; Witte DG; Carr TL; Manelli AM; Krueger KM; Cowart MD; Brioni JD; Esbenshade TA Assay Drug Dev Technol; 2008 Jun; 6(3):339-49. PubMed ID: 18593375 [TBL] [Abstract][Full Text] [Related]
55. Analysis of agonism and inverse agonism in functional assays with constitutive activity: estimation of orthosteric ligand affinity constants for active and inactive receptor states. Ehlert FJ; Suga H; Griffin MT J Pharmacol Exp Ther; 2011 Aug; 338(2):671-86. PubMed ID: 21576379 [TBL] [Abstract][Full Text] [Related]
56. Constitutive activities and inverse agonism in dopamine receptors. Zhang B; Albaker A; Plouffe B; Lefebvre C; Tiberi M Adv Pharmacol; 2014; 70():175-214. PubMed ID: 24931197 [TBL] [Abstract][Full Text] [Related]
57. Being mindful of seven-transmembrane receptor 'guests' when assessing agonist selectivity. Kenakin T Br J Pharmacol; 2010 Jul; 160(5):1045-7. PubMed ID: 20590598 [TBL] [Abstract][Full Text] [Related]
58. Constitutive activity and inverse agonism at the α(₁a) and α(₁b) adrenergic receptor subtypes. Cotecchia S Methods Enzymol; 2010; 485():123-38. PubMed ID: 21050914 [TBL] [Abstract][Full Text] [Related]